Detalhe da pesquisa
1.
Oseltamivir-resistant pandemic A/H1N1 virus is as virulent as its wild-type counterpart in mice and ferrets.
PLoS Pathog
; 6(7): e1001015, 2010 Jul 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-20661429
2.
A nasal proteosome adjuvant activates microglia and prevents amyloid deposition.
Ann Neurol
; 63(5): 591-601, 2008 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-18360829
3.
Nasal delivery of Protollin-adjuvanted H5N1 vaccine induces enhanced systemic as well as mucosal immunity in mice.
Vaccine
; 35(25): 3318-3325, 2017 06 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-28499553
4.
Methylglycol chitosan and a synthetic TLR4 agonist enhance immune responses to influenza vaccine administered sublingually.
Vaccine
; 33(43): 5845-5853, 2015 Oct 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-26392012
5.
Effects of different adjuvants in the context of intramuscular and intranasal routes on humoral and cellular immune responses induced by detergent-split A/H3N2 influenza vaccines in mice.
Clin Vaccine Immunol
; 19(2): 209-18, 2012 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-22190392
6.
Proteosome-adjuvanted intranasal influenza vaccines: advantages, progress and future considerations.
Expert Rev Vaccines
; 10(3): 365-75, 2011 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-21434804
7.
A novel intranasal Protollin-based measles vaccine induces mucosal and systemic neutralizing antibody responses and cell-mediated immunity in mice.
Vaccine
; 23(11): 1374-83, 2005 Feb 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-15661386
8.
A nasal Proteosome influenza vaccine containing baculovirus-derived hemagglutinin induces protective mucosal and systemic immunity.
Vaccine
; 21(25-26): 3706-12, 2003 Sep 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-12922101